OTCMKTS:AUGX Augmedix (AUGX) Stock Price, News & Analysis → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free AUGX Stock Alerts $2.99 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$2.95▼$3.1150-Day Range$2.99▼$4.7052-Week Range$2.62▼$6.25Volume182,445 shsAverage Volume372,086 shsMarket Capitalization$145.73 millionP/E RatioN/ADividend YieldN/APrice Target$6.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings Get Augmedix alerts: Email Address Augmedix MarketRank™ Stock AnalysisAnalyst Rating0.00 Rating ScoreUpside/Downside117.4% Upside$6.50 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.48) to ($0.36) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.61 out of 5 stars 2.0 Analyst's Opinion Amount of Analyst CoverageAugmedix has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for AUGX. Previous Next 0.0 Dividend Strength Dividend YieldAugmedix does not currently pay a dividend.Dividend GrowthAugmedix does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AUGX. Previous Next 1.9 News and Social Media Coverage News SentimentAugmedix has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Augmedix this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for AUGX on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.MarketBeat Follows1 people have added Augmedix to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Augmedix insiders have not sold or bought any company stock.Percentage Held by Insiders10.97% of the stock of Augmedix is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.11% of the stock of Augmedix is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Augmedix are expected to grow in the coming year, from ($0.48) to ($0.36) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Augmedix is -5.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Augmedix is -5.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAugmedix has a P/B Ratio of 29.90. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Augmedix Stock (OTCMKTS:AUGX)Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.Read More AUGX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AUGX Stock News HeadlinesApril 18, 2024 | americanbankingnews.comHead to Head Comparison: Augmedix (OTCMKTS:AUGX) versus Mobile-health Network Solutions (NASDAQ:MNDR)April 14, 2024 | americanbankingnews.comAugmedix (OTCMKTS:AUGX) versus Zhongchao (NASDAQ:ZCMD) Head-To-Head SurveyApril 23, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.April 10, 2024 | finance.yahoo.comAugmedix Inc (AUGX) Chief Strategy Officer Ian Shakil Sells 89,167 SharesApril 4, 2024 | uk.finance.yahoo.comAugmedix Inc (AUGX) Chief Strategy Officer Ian Shakil Sells 97,441 SharesApril 4, 2024 | finanznachrichten.deAugmedix Inc: Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems NationwideMarch 19, 2024 | finanznachrichten.deAugmedix Inc: Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023March 19, 2024 | markets.businessinsider.comBenchmark Co. Keeps Their Buy Rating on Augmedix (AUGX)April 23, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.March 18, 2024 | investorplace.comAUGX Stock Earnings: Augmedix Beats EPS, Beats Revenue for Q4 2023March 18, 2024 | finance.yahoo.comAugmedix Inc (AUGX) Reports Strong Revenue Growth and Margin Expansion in Q4 and Full Year 2023March 16, 2024 | finance.yahoo.comAUGX Mar 2024 7.500 callMarch 16, 2024 | finance.yahoo.comAUGX Apr 2024 5.000 callMarch 12, 2024 | finanznachrichten.deAugmedix Inc: Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix GoFebruary 25, 2024 | edition.cnn.comAugmedix IncFebruary 15, 2024 | bizjournals.comDaily Digest: Cisco releases layoff total; A's in Coliseum extension talksFebruary 13, 2024 | finance.yahoo.comAugmedix Names Tomer Levy as New Senior Vice President of EngineeringJanuary 30, 2024 | markets.businessinsider.comBuy Rating Affirmed for Augmedix Amid Funding Success and Strong Growth ProspectsJanuary 16, 2024 | finance.yahoo.comAugmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor ConferenceJanuary 7, 2024 | benzinga.comAugmedix Stock (NASDAQ:AUGX) Dividends: History, Yield and DatesJanuary 6, 2024 | msn.comAugmedix says Q4 revenue is expected to be about $12.5MDecember 13, 2023 | finance.yahoo.comAugmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient DocumentationDecember 9, 2023 | finance.yahoo.comAugmedix, Inc. (NASDAQ:AUGX) has caught the attention of hedge funds investors who hold a sizeable 40% stakeNovember 27, 2023 | msn.comAugmedix (AUGX) Price Target Increased by 7.60% to 7.82November 24, 2023 | uk.finance.yahoo.comAugmedix, Inc. (AUGX)November 16, 2023 | investorplace.comWhy Is Augmedix (AUGX) Stock Down 27% Today?November 15, 2023 | finance.yahoo.comAugmedix Announces Proposed Public Offering of 5,500,000 Shares of Common StockSee More Headlines Receive AUGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/18/2024Today4/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolOTCMKTS:AUGX CUSIPN/A CIK1769804 Webwww.augmedix.com Phone888-669-4885FaxN/AEmployees1,430Year FoundedN/APrice Target and Rating Average Stock Price Target$6.50 High Stock Price Target$6.50 Low Stock Price Target$6.50 Potential Upside/Downside+117.4%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($0.45) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-24,450,000.00 Net Margins-57.70% Pretax Margin-57.23% Return on Equity-980.09% Return on Assets-57.85% Debt Debt-to-Equity Ratio3.74 Current Ratio1.70 Quick Ratio1.70 Sales & Book Value Annual Sales$44.86 million Price / Sales3.25 Cash FlowN/A Price / Cash FlowN/A Book Value$0.10 per share Price / Book29.90Miscellaneous Outstanding Shares48,740,000Free Float36,316,000Market Cap$145.73 million OptionableNot Optionable Beta-0.16 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Emmanuel Krakaris (Age 65)President, CEO, Secretary & Director Comp: $734.33kMr. Ian Shakil (Age 39)Founder, Chief Strategy Officer & Director Ms. Sandra Breber (Age 66)Chief Operating Officer Comp: $446.05kMr. Saurav Chatterjee Ph.D. (Age 52)Chief Technology Officer Comp: $438.05kMr. Paul Louis Ginocchio (Age 54)Chief Financial Officer Todd HolvickHead of Legal & ComplianceLia WallickHead of PeopleDr. Davin Lundquist M.D.Chief Medical OfficerMr. Jonathan Hawkins (Age 54)Chief Revenue Officer Comp: $417.71kMr. Tomer LevySenior Vice President of EngineeringMore ExecutivesKey CompetitorsMSP RecoveryNASDAQ:LIFWForianNASDAQ:FORAscPharmaceuticalsNASDAQ:SCPHInfuSystemNYSEAMERICAN:INFURegulus TherapeuticsNASDAQ:RGLSView All CompetitorsInsidersMargie L TraylorBought 26,530 shares on 6/14/2023Total: $119,650.30 ($4.51/share)View All Insider Transactions AUGX Stock Analysis - Frequently Asked Questions What is Augmedix's stock price target for 2024? 0 analysts have issued 1-year price targets for Augmedix's stock. Their AUGX share price targets range from $6.50 to $6.50. On average, they anticipate the company's stock price to reach $6.50 in the next twelve months. This suggests a possible upside of 117.4% from the stock's current price. View analysts price targets for AUGX or view top-rated stocks among Wall Street analysts. How have AUGX shares performed in 2024? Augmedix's stock was trading at $5.85 at the beginning of 2024. Since then, AUGX shares have decreased by 48.9% and is now trading at $2.99. View the best growth stocks for 2024 here. How were Augmedix's earnings last quarter? Augmedix, Inc. (OTCMKTS:AUGX) announced its quarterly earnings data on Monday, March, 18th. The company reported ($0.09) earnings per share for the quarter. The company had revenue of $12.68 million for the quarter, compared to analysts' expectations of $12.30 million. Augmedix had a negative trailing twelve-month return on equity of 980.09% and a negative net margin of 57.70%. How do I buy shares of Augmedix? Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:AUGX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
